The ‘Luminal B’ breast cancer has been recognised as having worst prognosis, these characteristics were similar in our cohort of patients, but superior to ‘HER2- enriched’ and ‘basal-like tumours’ [23]. This evidence concerns the gene ERBB2 and breast carcinoma.